Antibodies that specifically bind to gmad
CA 2480052 A1 · Owner: Chowdhury, Partha · Inventors: Chowdhury, Partha; Albert, Vivian R.; Baker, Kevin P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to antibodies and related molecules that immunospecifically bind to GMAD. Such antibodies have uses for example, in , the prevention and treatment of both insulin- and non insulin-dependent diabetes mellitus (i.e. Type I and Type II diabetes) and other related disorders. The invention also relates to nucleic acid molecules encoding anti- GMAD antibodies, vectors and host cells containing these nucleic acids and , methods for producing the same. The present invention relates to methods and compositions for preventing, detecting diagnosing, treating or ameliorating a disease or disorder, especially diabetes and other related disorders comprising …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 28, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 28, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 28, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.